Medicxi closes fund worth nearly $449 million, aims for investments in platforms, pipelines
While it trails its U.S. counterpart, Europe's life science sector has seen an increase in interest from investors lately. A report released Thursday by Silicon Valley Bank indicates growing investment in European biopharma and diagnostics.